Evidence map›Paper›PMID 17216133›Full record

ArticleInternational urogynecology journal and pelvic floor dysfunction2007

A long-term review of posterior colporrhaphy with Vypro 2 mesh.

Yik Nyok Lim, Reinhold Muller, Audrey Corstiaans, Sarah Hitchins, Christopher Barry, Ajay Rane

Abstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal and pelvic floor dysfunction, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Pelvic organ prolapse and sexual function.Nature reviews. Urology · 2020
    Review
  3. Article
  4. Observational
  5. Article
  6. Management of pelvic organ prolapse.Korean journal of urology · 2014
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review of synthetic mesh-related complications in pelvic floor reconstructive surgery.International urogynecology journal and pelvic floor dysfunction · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yik Nyok LimDepartment of Urogynecology, Mercy Hospital for Women, 163 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia. yik_lim@yahoo.com.au
Reinhold Muller
Audrey Corstiaans
Sarah Hitchins
Christopher Barry
Ajay Rane

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective is to study the long-term outcomes of posterior colporrhaphy with composite polyglactin 910-polypropylene mesh (Vypro 2, Ethicon, Somerville, NJ, USA) utilizing an overlay technique. Seventy-eight patients involved in our previous study were contacted 3 years after their initial operation for follow-up (Lim YN, Rane A, Muller R, Int Urogynecol J 16:126-131, 2005). Thirty-seven (47%) returned for follow-up and completed a standardized questionnaire survey, whereas a further 16 (20%) returned their postal questionnaires. Mean age was 61.3 (SD 10.8) years, and follow-up was 35.7 (SD 4.5) months. There were statistically significant improvements in vaginal lump sensation and constipation (p < 0.001) but no differences with defecatory difficulties or dyspareunia. De novo dyspareunia was reported in 27%. On examination, the incidences of mesh vaginal erosion and rectocele recurrence were 30% and 22%, respectively. It appears that posterior colporrhaphy incorporating Vypro 2 mesh with an overlay method is associated with unacceptably high incidence of complications.

Indexed as

Surgical MeshAgedCohort StudiesFemaleFollow-Up StudiesGynecologic Surgical ProceduresHealth SurveysHumansLongitudinal StudiesMiddle AgedPolypropylenesTreatment OutcomeUrinary IncontinenceUterine ProlapseVaginaPolypropylenes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.